287 related articles for article (PubMed ID: 30387390)
1. Novel Topical Nanocarriers for Treatment of Psoriasis: An Overview.
Dadwal A; Mishra N; Narang RK
Curr Pharm Des; 2018; 24(33):3934-3950. PubMed ID: 30387390
[TBL] [Abstract][Full Text] [Related]
2. Novel drug delivery systems in topical treatment of psoriasis: rigors and vigors.
Katare OP; Raza K; Singh B; Dogra S
Indian J Dermatol Venereol Leprol; 2010; 76(6):612-21. PubMed ID: 21079304
[TBL] [Abstract][Full Text] [Related]
3. Novel colloidal carriers for psoriasis: current issues, mechanistic insight and novel delivery approaches.
Pradhan M; Singh D; Singh MR
J Control Release; 2013 Sep; 170(3):380-95. PubMed ID: 23770117
[TBL] [Abstract][Full Text] [Related]
4. Nanocarriers Mediated Topical Drug Delivery for Psoriasis Treatment.
Gungor S; Rezigue M
Curr Drug Metab; 2017; 18(5):454-468. PubMed ID: 28228078
[TBL] [Abstract][Full Text] [Related]
5. Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis.
Doppalapudi S; Jain A; Chopra DK; Khan W
Eur J Pharm Sci; 2017 Jan; 96():515-529. PubMed ID: 27777066
[TBL] [Abstract][Full Text] [Related]
6. Solid lipid nanoparticles-loaded topical gel containing combination drugs: an approach to offset psoriasis.
Sonawane R; Harde H; Katariya M; Agrawal S; Jain S
Expert Opin Drug Deliv; 2014 Dec; 11(12):1833-47. PubMed ID: 25078031
[TBL] [Abstract][Full Text] [Related]
7. A Promising Approach of Dermal Targeting of Antipsoriatic Drugs
Tripathi D; Srivastava M; Rathour K; Rai AK; Wal P; Sahoo J; Tiwari RK; Pandey P
Drug Metab Bioanal Lett; 2023; 16(2):89-104. PubMed ID: 37534794
[TBL] [Abstract][Full Text] [Related]
8. Exploring the potential of nanocarriers in antipsoriatic therapeutics.
Shaif M; Kushwaha P; Usmani S; Pandey S
J Dermatolog Treat; 2022 Nov; 33(7):2919-2930. PubMed ID: 35729857
[TBL] [Abstract][Full Text] [Related]
9. Insightful exploring of advanced nanocarriers for the topical/transdermal treatment of skin diseases.
El-Zaafarany GM; Nasr M
Pharm Dev Technol; 2021 Dec; 26(10):1136-1157. PubMed ID: 34751091
[TBL] [Abstract][Full Text] [Related]
10. Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals.
Puglia C; Bonina F
Expert Opin Drug Deliv; 2012 Apr; 9(4):429-41. PubMed ID: 22394125
[TBL] [Abstract][Full Text] [Related]
11. Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy.
Rahman M; Akhter S; Ahmad J; Ahmad MZ; Beg S; Ahmad FJ
Expert Opin Drug Deliv; 2015 Apr; 12(4):635-52. PubMed ID: 25439967
[TBL] [Abstract][Full Text] [Related]
12. Recent Advancement in Topical Nanocarriers for the Treatment of Psoriasis.
Biswasroy P; Pradhan D; Kar B; Ghosh G; Rath G
AAPS PharmSciTech; 2021 May; 22(5):164. PubMed ID: 34041632
[TBL] [Abstract][Full Text] [Related]
13. Pivotal role of Acitretin nanovesicular gel for effective treatment of psoriasis: ex vivo-in vivo evaluation study.
Abu Hashim II; Abo El-Magd NF; El-Sheakh AR; Hamed MF; Abd El-Gawad AEH
Int J Nanomedicine; 2018; 13():1059-1079. PubMed ID: 29503541
[TBL] [Abstract][Full Text] [Related]
14. Solid lipid nanoparticles: promising therapeutic nanocarriers for drug delivery.
Thukral DK; Dumoga S; Mishra AK
Curr Drug Deliv; 2014; 11(6):771-91. PubMed ID: 25469779
[TBL] [Abstract][Full Text] [Related]
15. An overview of topical lipid-based and polymer-based nanocarriers for treatment of psoriasis.
Aziz Hazari S; Kaur H; Karwasra R; Abourehab MAS; Ali Khan A; Kesharwani P
Int J Pharm; 2023 May; 638():122938. PubMed ID: 37031809
[TBL] [Abstract][Full Text] [Related]
16. Nanoemulsions (NEs), liposomes (LPs) and solid lipid nanoparticles (SLNs) for retinyl palmitate: effect on skin permeation.
Clares B; Calpena AC; Parra A; Abrego G; Alvarado H; Fangueiro JF; Souto EB
Int J Pharm; 2014 Oct; 473(1-2):591-8. PubMed ID: 25102113
[TBL] [Abstract][Full Text] [Related]
17. Development characterization and skin permeating potential of lipid based novel delivery system for topical treatment of psoriasis.
Pradhan M; Singh D; Singh MR
Chem Phys Lipids; 2015 Feb; 186():9-16. PubMed ID: 25447290
[TBL] [Abstract][Full Text] [Related]
18. Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity.
Raza K; Singh B; Lohan S; Sharma G; Negi P; Yachha Y; Katare OP
Int J Pharm; 2013 Nov; 456(1):65-72. PubMed ID: 23973754
[TBL] [Abstract][Full Text] [Related]
19. An Overview on Promising Nanotechnological Approaches for the Treatment of Psoriasis.
Pandey K; Nimisha
Recent Pat Nanotechnol; 2020; 14(2):102-118. PubMed ID: 32013854
[TBL] [Abstract][Full Text] [Related]
20. Advances in psoriasis physiopathology and treatments: Up to date of mechanistic insights and perspectives of novel therapies based on innovative skin drug delivery systems (ISDDS).
Sala M; Elaissari A; Fessi H
J Control Release; 2016 Oct; 239():182-202. PubMed ID: 27381248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
